Suppr超能文献

人脂肪组织溶解膜中胰高血糖素和胰高血糖素样肽-1-(7-36)酰胺受体的存在。

Presence of glucagon and glucagon-like peptide-1-(7-36)amide receptors in solubilized membranes of human adipose tissue.

作者信息

Mérida E, Delgado E, Molina L M, Villanueva-Peñacarrillo M L, Valverde I

机构信息

Fundación Jiménez Díaz, Madrid, Spain.

出版信息

J Clin Endocrinol Metab. 1993 Dec;77(6):1654-7. doi: 10.1210/jcem.77.6.8263154.

Abstract

Specific receptors for glucagon and for glucagon-like peptide-1 (GLP-1) (7-36)amide have been found in solubilized human adipose membranes. The 50% inhibition dose of the corresponding unlabeled peptide was near to their physiological levels [ID50, 0.5 nmol/L for glucagon and 1.0 nmol/L for GLP-1(7-36)amide;]. In both cases, the presence of high affinity receptors was evident [Kd, 0.5 and 0.7 nmol/L for glucagon and GLP-1(7-36)amide, respectively]; the high affinity maximal binding capacity for GLP-1(7-36)amide was higher than that for glucagon (893 and 117 fmol/mg solubilized fat membranes, respectively). Glucagon at 10(-6) mol/L did not compete with the [125I]GLP-1(7-36)amide binding, nor did GLP-1(7-36)amide (10(-6) mol/L) compete with that of [125I]glucagon. The relative abundance of GLP-1(7-36)amide receptors in human adipose tissue is further support for a direct and probably important action of this peptide in the metabolism of the fat cell.

摘要

在可溶解的人脂肪细胞膜中已发现胰高血糖素和胰高血糖素样肽-1(GLP-1)(7-36)酰胺的特异性受体。相应未标记肽的半数抑制剂量接近其生理水平[ID50,胰高血糖素为0.5 nmol/L,GLP-1(7-36)酰胺为1.0 nmol/L]。在这两种情况下,高亲和力受体的存在都很明显[胰高血糖素和GLP-1(7-36)酰胺的Kd分别为0.5和0.7 nmol/L];GLP-1(7-36)酰胺的高亲和力最大结合能力高于胰高血糖素(分别为893和117 fmol/mg可溶解脂肪膜)。10^(-6) mol/L的胰高血糖素不与[125I]GLP-1(7-36)酰胺结合竞争,10^(-6) mol/L的GLP-1(7-36)酰胺也不与[125I]胰高血糖素竞争。人脂肪组织中GLP-1(7-36)酰胺受体的相对丰度进一步支持了该肽在脂肪细胞代谢中的直接且可能重要的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验